Logo image of SQNS

SEQUANS COMMUNICATIONS-ADR (SQNS) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:SQNS - US8173234050 - ADR

6.48 USD
-0.27 (-4%)
Last: 12/10/2025, 7:00:00 PM
6.4 USD
-0.08 (-1.23%)
After Hours: 12/10/2025, 7:00:00 PM
Fundamental Rating

1

Overall SQNS gets a fundamental rating of 1 out of 10. We evaluated SQNS against 112 industry peers in the Semiconductors & Semiconductor Equipment industry. Both the profitability and financial health of SQNS have multiple concerns. SQNS is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year SQNS has reported negative net income.
SQNS had a negative operating cash flow in the past year.
SQNS had negative earnings in 4 of the past 5 years.
In the past 5 years SQNS always reported negative operating cash flow.
SQNS Yearly Net Income VS EBIT VS OCF VS FCFSQNS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M

1.2 Ratios

SQNS's Return On Assets of -5.80% is on the low side compared to the rest of the industry. SQNS is outperformed by 68.75% of its industry peers.
SQNS has a worse Return On Equity (-11.09%) than 69.64% of its industry peers.
Industry RankSector Rank
ROA -5.8%
ROE -11.09%
ROIC N/A
ROA(3y)2.44%
ROA(5y)-15.56%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SQNS Yearly ROA, ROE, ROICSQNS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 1K 1.5K 2K

1.3 Margins

SQNS's Gross Margin of 62.26% is amongst the best of the industry. SQNS outperforms 87.50% of its industry peers.
SQNS's Gross Margin has improved in the last couple of years.
SQNS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 62.26%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.12%
GM growth 5Y13.43%
SQNS Yearly Profit, Operating, Gross MarginsSQNS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100 -100 150

1

2. Health

2.1 Basic Checks

SQNS does not have a ROIC to compare to the WACC, probably because it is not profitable.
SQNS has more shares outstanding than it did 1 year ago.
SQNS has more shares outstanding than it did 5 years ago.
The debt/assets ratio for SQNS has been reduced compared to a year ago.
SQNS Yearly Shares OutstandingSQNS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
SQNS Yearly Total Debt VS Total AssetsSQNS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

An Altman-Z score of 2.71 indicates that SQNS is not a great score, but indicates only limited risk for bankruptcy at the moment.
SQNS has a Altman-Z score of 2.71. This is comparable to the rest of the industry: SQNS outperforms 41.07% of its industry peers.
A Debt/Equity ratio of 0.70 indicates that SQNS is somewhat dependend on debt financing.
SQNS's Debt to Equity ratio of 0.70 is on the low side compared to the rest of the industry. SQNS is outperformed by 76.79% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF N/A
Altman-Z 2.71
ROIC/WACCN/A
WACC11.75%
SQNS Yearly LT Debt VS Equity VS FCFSQNS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

2.3 Liquidity

SQNS has a Current Ratio of 0.97. This is a bad value and indicates that SQNS is not financially healthy enough and could expect problems in meeting its short term obligations.
SQNS's Current ratio of 0.97 is on the low side compared to the rest of the industry. SQNS is outperformed by 91.96% of its industry peers.
SQNS has a Quick Ratio of 0.97. This is a bad value and indicates that SQNS is not financially healthy enough and could expect problems in meeting its short term obligations.
SQNS's Quick ratio of 0.87 is on the low side compared to the rest of the industry. SQNS is outperformed by 87.50% of its industry peers.
Industry RankSector Rank
Current Ratio 0.97
Quick Ratio 0.87
SQNS Yearly Current Assets VS Current LiabilitesSQNS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

4

3. Growth

3.1 Past

The earnings per share for SQNS have decreased strongly by -140.85% in the last year.
Looking at the last year, SQNS shows a small growth in Revenue. The Revenue has grown by 3.20% in the last year.
SQNS shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.60% yearly.
EPS 1Y (TTM)-140.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-102.71%
Revenue 1Y (TTM)3.2%
Revenue growth 3Y-10.21%
Revenue growth 5Y3.6%
Sales Q2Q%-57.45%

3.2 Future

Based on estimates for the next years, SQNS will show a very negative growth in Earnings Per Share. The EPS will decrease by -26.77% on average per year.
Based on estimates for the next years, SQNS will show a very strong growth in Revenue. The Revenue will grow by 25.48% on average per year.
EPS Next Y-116.87%
EPS Next 2Y-42.92%
EPS Next 3Y-26.77%
EPS Next 5YN/A
Revenue Next Year-24.26%
Revenue Next 2Y13.48%
Revenue Next 3Y12.17%
Revenue Next 5Y25.48%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
SQNS Yearly Revenue VS EstimatesSQNS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 20M 40M 60M 80M
SQNS Yearly EPS VS EstimatesSQNS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 20 -20 -40

0

4. Valuation

4.1 Price/Earnings Ratio

SQNS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SQNS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SQNS Price Earnings VS Forward Price EarningsSQNS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SQNS Per share dataSQNS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -2 -4 -6

4.3 Compensation for Growth

A cheap valuation may be justified as SQNS's earnings are expected to decrease with -26.77% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-42.92%
EPS Next 3Y-26.77%

0

5. Dividend

5.1 Amount

SQNS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

SEQUANS COMMUNICATIONS-ADR

NYSE:SQNS (12/10/2025, 7:00:00 PM)

After market: 6.4 -0.08 (-1.23%)

6.48

-0.27 (-4%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)11-04 2025-11-04/bmo
Earnings (Next)02-09 2026-02-09/amc
Inst Owners54.19%
Inst Owner Change-79.96%
Ins Owners0.96%
Ins Owner ChangeN/A
Market Cap928.74M
Revenue(TTM)31.53M
Net Income(TTM)-25.03M
Analysts82.22
Price Target21.08 (225.31%)
Short Float %3.3%
Short Ratio1.38
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)19.61%
Min EPS beat(2)-1.2%
Max EPS beat(2)40.42%
EPS beat(4)2
Avg EPS beat(4)11.51%
Min EPS beat(4)-12.04%
Max EPS beat(4)40.42%
EPS beat(8)5
Avg EPS beat(8)110.6%
EPS beat(12)7
Avg EPS beat(12)71.82%
EPS beat(16)11
Avg EPS beat(16)72.35%
Revenue beat(2)0
Avg Revenue beat(2)-40.53%
Min Revenue beat(2)-48.17%
Max Revenue beat(2)-32.9%
Revenue beat(4)2
Avg Revenue beat(4)-17.22%
Min Revenue beat(4)-48.17%
Max Revenue beat(4)9.67%
Revenue beat(8)4
Avg Revenue beat(8)-0.85%
Revenue beat(12)4
Avg Revenue beat(12)-4.82%
Revenue beat(16)5
Avg Revenue beat(16)-3.79%
PT rev (1m)-62.42%
PT rev (3m)275.76%
EPS NQ rev (1m)-15.48%
EPS NQ rev (3m)-223.33%
EPS NY rev (1m)47.46%
EPS NY rev (3m)-248.6%
Revenue NQ rev (1m)-4.98%
Revenue NQ rev (3m)-21.57%
Revenue NY rev (1m)-10.1%
Revenue NY rev (3m)-19.85%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 29.45
P/FCF N/A
P/OCF N/A
P/B 4.11
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-7.19
EYN/A
EPS(NY)-0.96
Fwd EYN/A
FCF(TTM)-3.01
FCFYN/A
OCF(TTM)-0.35
OCFYN/A
SpS0.22
BVpS1.57
TBVpS-1.07
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -5.8%
ROE -11.09%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 62.26%
FCFM N/A
ROA(3y)2.44%
ROA(5y)-15.56%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.12%
GM growth 5Y13.43%
F-Score0
Asset Turnover0.07
Health
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 5671.09%
Cap/Sales 1207.99%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.97
Quick Ratio 0.87
Altman-Z 2.71
F-Score0
WACC11.75%
ROIC/WACCN/A
Cap/Depr(3y)234.19%
Cap/Depr(5y)223.55%
Cap/Sales(3y)59.67%
Cap/Sales(5y)52.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-140.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-102.71%
EPS Next Y-116.87%
EPS Next 2Y-42.92%
EPS Next 3Y-26.77%
EPS Next 5YN/A
Revenue 1Y (TTM)3.2%
Revenue growth 3Y-10.21%
Revenue growth 5Y3.6%
Sales Q2Q%-57.45%
Revenue Next Year-24.26%
Revenue Next 2Y13.48%
Revenue Next 3Y12.17%
Revenue Next 5Y25.48%
EBIT growth 1Y3.1%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year23.45%
EBIT Next 3Y19.84%
EBIT Next 5YN/A
FCF growth 1Y-1868.28%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1247.79%
OCF growth 3YN/A
OCF growth 5YN/A

SEQUANS COMMUNICATIONS-ADR / SQNS FAQ

What is the ChartMill fundamental rating of SEQUANS COMMUNICATIONS-ADR (SQNS) stock?

ChartMill assigns a fundamental rating of 1 / 10 to SQNS.


What is the valuation status of SEQUANS COMMUNICATIONS-ADR (SQNS) stock?

ChartMill assigns a valuation rating of 0 / 10 to SEQUANS COMMUNICATIONS-ADR (SQNS). This can be considered as Overvalued.


What is the profitability of SQNS stock?

SEQUANS COMMUNICATIONS-ADR (SQNS) has a profitability rating of 1 / 10.


How financially healthy is SEQUANS COMMUNICATIONS-ADR?

The financial health rating of SEQUANS COMMUNICATIONS-ADR (SQNS) is 1 / 10.


What is the earnings growth outlook for SEQUANS COMMUNICATIONS-ADR?

The Earnings per Share (EPS) of SEQUANS COMMUNICATIONS-ADR (SQNS) is expected to decline by -116.87% in the next year.